Annual report [Section 13 and 15(d), not S-K Item 405]

INCOME TAXES

v3.25.0.1
INCOME TAXES
12 Months Ended
Dec. 31, 2024
Notes to Financial Statements  
INCOME TAXES

NOTE 12 INCOME TAXES

Income Tax (Benefit) Expense

Components of income tax (benefit) expense were as follows (in thousands):

Year Ended December 31, 

    

2024

    

2023

    

2022

Current

$

92

$

(140)

$

8,476

Deferred

 

(10,077)

 

18,485

 

45,184

Total income tax (benefit) expense

$

(9,985)

$

18,345

$

53,660

Reconciliation

The Company’s income tax (benefit) expense for 2024, 2023 and 2022 resulted in effective tax rates of 10.3%, 54.0% and 18.8%, respectively. The reconciliation of income taxes computed at the U.S. federal statutory tax rate of 21% to these effective tax rates is as follows (in thousands):

Year Ended December 31, 

    

2024

    

2023

    

2022

Income tax (benefit) expense at the federal statutory rate

$

(20,397)

$

7,128

$

59,810

Compensation adjustments

 

2,607

 

1,752

 

599

State income taxes

 

(57)

 

1,143

 

2,418

Valuation allowance

 

7,699

 

8,125

 

(9,117)

Other

 

163

 

197

 

(50)

Income tax (benefit) expense

$

(9,985)

$

18,345

$

53,660

Deferred Tax Assets and Liabilities

Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant components of the Company’s deferred tax assets and liabilities were as follows (in thousands):

December 31, 

    

2024

    

2023

Deferred tax assets:

 

  

 

  

Derivatives

$

4,376

$

8,532

Asset retirement obligations

 

118,398

 

109,111

Contingent asset retirement obligations

4,493

3,952

Right of use liability

2,743

2,895

Federal net operating losses

 

10,805

 

6,211

State net operating losses

 

4,581

 

5,941

Interest expense limitation carryover

 

24,947

 

17,501

Share-based compensation

 

1,480

 

2,262

Other

 

4,560

 

4,266

Total deferred tax asset

176,383

160,671

Valuation allowance

 

(29,155)

 

(23,202)

Total deferred tax asset after valuation allowance

 

147,228

 

137,469

Deferred tax liabilities:

  

  

Property and equipment

$

93,284

$

92,707

Investment in non-consolidated entity

 

2,149

 

2,993

Other

 

2,995

 

3,046

Total deferred tax liabilities

 

98,428

 

98,746

Net deferred tax asset (1)

$

48,800

$

38,723

(1) As of December 31, 2024 and 2023, $8 thousand and $51 thousand are included in Other liabilities in the Company’s Consolidated Balance Sheets.

Valuation Allowance

Changes to the Company’s valuation allowance are as follows (in thousands):

Year Ended December 31, 

    

2024

    

2023

    

2022

Balance at beginning of period

$

(23,202)

$

(15,311)

$

(24,359)

Additions to valuation allowance

(5,953)

(7,891)

Reductions to valuation allowance

9,048

Balance at end of period

$

(29,155)

$

(23,202)

$

(15,311)

Deferred tax assets are recorded related to net operating losses (“NOLs”) and temporary differences between the book and tax basis of assets and liabilities expected to produce tax deductions in future periods. The Company records valuation allowances when it is more likely than not that some portion or all of its deferred tax assets will not be realized. As of each reporting date, the Company assesses available positive and negative evidence regarding its ability to realize its deferred tax assets, including reversing temporary differences and projections of future taxable income during the periods in which those temporary differences become deductible, as well as negative evidence such as historical losses, to evaluate the realizability of its net deferred tax asset position. The realization of these assets depends on recognition of sufficient future taxable income in specific tax jurisdictions in which those temporary differences or NOLs are deductible.

The amount of the Company’s deferred tax assets considered realizable could be adjusted if projections of future taxable income are reduced or objective negative evidence in the form of a three–year cumulative loss is present or both. Should the Company no longer have a level of sustained profitability, it will have to rely more on its future projections of taxable income to determine if the Company has an adequate source of taxable income for the realization of its deferred tax assets, namely NOLs and interest expense limitations.

Net Operating Loss and Interest Expense Limitation Carryover

The table below presents the details of the Company’s net operating loss and interest expense limitation carryover as of December 31, 2024 (in thousands):

    

Amount

    

Expiration
Year

Federal net operating loss

$

51,450

 

N/A

State net operating loss

 

104,109

 

2026 - 2043

Interest expense limitation carryover

 

115,495

 

N/A

Uncertain Tax Positions

The Company’s tax filings are subject to examination by federal and state tax authorities where it conducts its business. These examinations may result in assessments of additional tax that are resolved with the authorities or through the courts. The Company has evaluated whether any material tax positions it has taken will more likely than not be sustained upon examination by the appropriate taxing authority. As the Company believes that all such material tax positions it has taken are supportable by existing laws and related interpretations, the Company believes there are no material uncertain tax positions to consider.

Years Open to Examination

The Company and its subsidiaries are subject to income taxes in both the U.S. federal jurisdiction and state jurisdictions in which it conducts its business, each of which may have multiple open years subject to examination. As of December 31, 2024, the tax years 2021 through 2024 remain open to examination by the federal and state tax jurisdictions where the Company conducts its business.